ZURA Stock Analysis: Buy, Sell, or Hold?
ZURA - Zura Bio Limited Class A Ordinary Shares
$5.68
-0.35 (-5.80%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Get Alerted When ZURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ZURA is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ZURA is down 10.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ZURA is currently trading at $5.68, which is considered slightly high relative to its 30-day fair value range of $4.70 to $6.00.
Technical Outlook: Technically, ZURA is in a strong uptrend. Immediate support is located at $4.41, while resistance sits at $6.63. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: ZURA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.60 (+158.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ZURA is in a strong uptrend. Immediate support is located at $4.41, while resistance sits at $6.63. Short-term momentum is weak, with the stock down 5.8% recently.
Market Sentiment: ZURA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $15.60 (+158.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$4.70 -
$6.00
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
79.2%
Protect Your Profits
Holding ZURA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.8%)
- BULLISH: Trading 158.7% below Wall St target ($15.60)
- WARNING: Recommendation downgraded due to -10.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$4.70 -
$6.00
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.92
(16.3%)
Support & Resistance Levels
Support Level
$4.41
Resistance Level
$6.63
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-7.78
Wall Street Target
$15.60
(+158.7%)
Last updated: January 30, 2026 7:31 PM ET
Data refreshes hourly during market hours. Next update: 8:31 PM
Data refreshes hourly during market hours. Next update: 8:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZURA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
Advanced ZURA Option Strategies
Professional options setups generated by AI based on today's ZURA price and gamma walls.
